Close



Apr 24, 2024 08:00AM
Apr 24, 2024 08:00AM
Apr 16, 2024 08:00AM
Apr 10, 2024 08:00AM
Mar 25, 2024 04:06PM
Mar 25, 2024 04:05PM
Mar 1, 2024 06:02AM Amneal Pharmaceuticals (AMRX) Tops Q4 EPS by 5c ; Offers Guidance
Mar 1, 2024 06:00AM
Feb 27, 2024 08:10AM
Feb 27, 2024 08:00AM
Feb 8, 2024 04:05PM
Jan 31, 2024 04:05PM
Jan 10, 2024 08:00AM
Jan 4, 2024 04:05PM Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023
Dec 15, 2023 04:05PM
Dec 15, 2023 04:05PM
Dec 7, 2023 08:10AM
Dec 7, 2023 08:00AM
Dec 1, 2023 08:00AM
Nov 7, 2023 06:02AM
Nov 7, 2023 06:00AM Amneal Reports Third Quarter 2023 Financial Results
Oct 23, 2023 04:05PM
Oct 12, 2023 08:00AM
Oct 5, 2023 08:00AM
Sep 6, 2023 04:00PM
Sep 6, 2023 04:00PM
Sep 6, 2023 08:01AM
Sep 6, 2023 08:01AM  Amneal Receives First Product Approval in China
Sep 6, 2023 08:00AM
Sep 6, 2023 08:00AM
Aug 29, 2023 04:01PM
Aug 24, 2023 04:01PM
Aug 4, 2023 06:01AM
Aug 4, 2023 06:00AM
Jul 26, 2023 08:03AM Amneal Pharmaceuticals (AMRX) Submits Abbreviated NDA to FDA for Three Key Complex Generics
Jul 26, 2023 08:00AM
Jul 6, 2023 08:00AM
Jul 5, 2023 05:45AM
Jul 5, 2023 05:45AM
Jul 3, 2023 02:01PM
Jul 3, 2023 02:00PM
Jun 14, 2023 08:01AM Amneal Pharmaceuticals (AMRX) Receives 505(b)(2) NDA Approval from FDA for PEMRYDI RTU®, a Ready-to-Use Oncology Injectable
Jun 14, 2023 08:00AM
May 16, 2023 08:00AM
May 5, 2023 06:03AM
May 5, 2023 06:00AM
Apr 17, 2023 08:24AM
Apr 17, 2023 06:31AM
Apr 17, 2023 06:30AM Amneal Reports Certain Preliminary First Quarter 2023 Financial Results and Affirms Full Year 2023 Financial Guidance
Apr 12, 2023 08:00AM

976,272 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All